Retinal Diseases

Retinal Diseases encompass a broad spectrum of vascular, degenerative, inflammatory, and hereditary conditions that compromise the structure and function of the retina. As a major theme at a global Ophthalmology Conference, this field highlights advances in early diagnosis, pharmacologic therapy, and surgical innovation aimed at preventing vision loss. Because the retina is essential for phototransduction and neural signal transmission, disorders affecting this tissue often result in progressive and sometimes irreversible visual decline. Comprehensive management of retinal disorders requires timely intervention and multidisciplinary coordination.

Common retinal diseases include diabetic retinopathy, retinal vein occlusion, age-related macular degeneration, inherited retinal dystrophies, and inflammatory retinopathies. Vascular compromise remains a leading cause of retinal damage, particularly in patients with systemic conditions such as diabetes and hypertension. Early detection through regular screening significantly reduces the risk of advanced proliferative disease and macular edema.

Diagnostic tools such as optical coherence tomography, fundus photography, wide-field angiography, and OCT angiography enable precise structural and vascular mapping. Functional testing through visual acuity measurement and electrophysiology complements imaging findings. Integration of artificial intelligence enhances early detection and progression analysis, especially in large-scale screening programs.

Therapeutic strategies vary depending on etiology. Intravitreal injections of anti-vascular endothelial growth factor agents and corticosteroids are widely used to treat macular edema and neovascularization. Laser photocoagulation remains effective in selected proliferative conditions. Surgical management through pars plana vitrectomy addresses complications such as vitreous hemorrhage and tractional retinal detachment.

Emerging research explores gene therapy for inherited retinal disorders, neuroprotective pharmacology, and regenerative approaches to restore damaged photoreceptors. Long-term disease monitoring and systemic risk factor control are essential in preventing recurrence or progression. Public health initiatives emphasize routine retinal examinations and integrated diabetes management programs.

By combining advanced imaging, targeted pharmacotherapy, and innovative surgical techniques, retinal disease management continues to evolve toward precision medicine and improved visual outcomes worldwide.